Ankylosing Spondylitis Trial, Recruiting NCT01422694 Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Condition: Ankylosing Spondylitis
Back to Ankylosing Spondylitis

Ankylosing Spondylitis Trial, Recruiting

NCT01422694
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with, or are suspected of having, a condition called spondyloarthropathy (SpA), which is a type of inflammatory joint disease.
  • Family members of people who have or are suspected of having SpA.
  • Healthy individuals who are willing to provide blood samples as a comparison group, as long as they are at least 6 years old and not pregnant.
  • Healthy volunteers who are willing to have imaging scans (of the spine/pelvis or whole body MRI) must be old enough to go through the scan without needing sedation, generally at least 6 years of age.
  • Pregnant people who have SpA may join, though they will not be asked to have an MRI, a skin sample taken, or a bone marrow sample taken.

Who may not be able to join:

  • People who are unable to give their own consent to participate, or children whose parent or guardian is not available to give consent on their behalf.
  • People who have another medical condition that, in the researchers' opinion, would make it hard to interpret the study results (confirm with trial site).
  • People who are not able to attend or keep up with the required follow-up visits.
  • Children under 2 years of age.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Sahar Lotfi-Emran, M.D., National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Phone: (240) 205-2837

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Registry
ClinicalTrials.gov
Start date
12 August 2011

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Progression from SpA to Axial Spa and to AS

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov